Blog

American Association for Cancer Research Conference on Optimizing Therapeutic Efficacy and Tolerability through Cancer Chemistry

www.aacr.org

Oct 28, 2024, 09:45

American Association for Cancer Research Conference on Optimizing Therapeutic Efficacy and Tolerability through Cancer Chemistry

American Association for Cancer Research shared a post on LinkedIn:

“Register by October 28 to get the lowest rates for the AACR Conference on Optimizing Therapeutic Efficacy and Tolerability through Cancer Chemistry (December 9-11, Toronto), chaired by Philip Jones, Angela N. Koehler, and Chudi Ndubaku and organized in association with the AACR Chemistry in Cancer Research Working Group.

Learn more.”

AACR AACR Conference American Association for Cancer Research Angela N. Koehler cancer cancer awareness cancer care Chudi Ndubaku fight against cancer Global fight against cancer OncoDaily Oncology Philip Jones

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage